These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11709701)

  • 1. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
    Koul D; Parthasarathy R; Shen R; Davies MA; Jasser SA; Chintala SK; Rao JS; Sun Y; Benvenisite EN; Liu TJ; Yung WK
    Oncogene; 2001 Oct; 20(46):6669-78. PubMed ID: 11709701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
    Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
    Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
    Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.
    Park MJ; Kim MS; Park IC; Kang HS; Yoo H; Park SH; Rhee CH; Hong SI; Lee SH
    Cancer Res; 2002 Nov; 62(21):6318-22. PubMed ID: 12414663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
    Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
    Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene.
    Lu W; Zhou X; Hong B; Liu J; Yue Z
    Cancer Lett; 2004 Oct; 214(2):205-13. PubMed ID: 15363547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway.
    Koul D; Yao Y; Abbruzzese JL; Yung WK; Reddy SA
    J Biol Chem; 2001 Apr; 276(14):11402-8. PubMed ID: 11278366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
    Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
    Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.
    Abe T; Terada K; Wakimoto H; Inoue R; Tyminski E; Bookstein R; Basilion JP; Chiocca EA
    Cancer Res; 2003 May; 63(9):2300-5. PubMed ID: 12727853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
    Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
    Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.
    Sano T; Lin H; Chen X; Langford LA; Koul D; Bondy ML; Hess KR; Myers JN; Hong YK; Yung WK; Steck PA
    Cancer Res; 1999 Apr; 59(8):1820-4. PubMed ID: 10213484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
    Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
    Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
    Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
    J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.
    Davies MA; Koul D; Dhesi H; Berman R; McDonnell TJ; McConkey D; Yung WK; Steck PA
    Cancer Res; 1999 Jun; 59(11):2551-6. PubMed ID: 10363971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
    Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A
    Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
    Tanaka M; Grossman HB
    Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.